• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 25

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Number of inspections completed by investigators and detailees based in-country during the monthOIPOffice of International ProgramsN/AN/A
2Number of high priority inspections completed by investigators and detailees based in-country during the monthOIPOffice of International ProgramsN/AN/A
3Number of routine inspections completed by investigators and detailees based in-country during the monthOIPOffice of International ProgramsN/AN/A
4Average number of days to complete an inspection in the monthOIPOffice of International ProgramsN/AN/A
5Number of investigators and detailees available to conduct inspections in the quarterOIPOffice of International ProgramsN/AN/A
6Number of verifications of foreign firm registrations completed in the monthOIPOffice of International ProgramsN/AN/A
7Number of workshops/conferences for regulatory authorities and industry held in foreign countries in which OIP participates during the monthOIPOffice of International ProgramsN/AN/A
8Number of workshops/conferences for regulatory authorities and industry held in the U.S. in which OIP staff participates during the monthOIPOffice of International ProgramsN/AN/A
9Number of inspections completed by investigators based in-country in the monthOIPOffice of International ProgramsN/AN/A
10Number of investigations completed by investigators based in-country in the monthOIPOffice of International ProgramsN/AN/A
11Number of verifications of foreign firm registrations completed in the monthOIPOffice of International ProgramsN/AN/A
12Train-the-trainer Good Clinical Practices (GCP)OIPOffice of International Programs - Africa OfficeN/AN/A
13Informatics PilotOIPOffice of International Programs - Asia-Pacific OfficeN/AN/A
14AQSIQ Regulatory AssessmentOIPOffice of International Programs - China OfficeN/AN/A
15Training on Good Clinical PracticesOIPOffice of International Programs - China OfficeN/AN/A
16FDA-EMA Tracking DatabaseOIPOffice of International Programs - Europe OfficeN/AN/A
17Regulatory Oversight BodiesOIPOffice of International Programs - India OfficeN/AN/A
18Pursue Agreement with Indian Counterparts to Facilitate Communication and CollaborationOIPOffice of International Programs - India OfficeN/AN/A
19Over-the-Counter (OTC) Good Manufacturing Practices (GMP) PilotOIPOffice of International Programs - India OfficeN/AN/A
20Database for Latin America RegionOIPOffice of International Programs - Latin America OfficeN/AN/A
21Library of Spanish Presentations on Key Frequently Requested FDA TopicsOIPOffice of International Programs - Latin America OfficeN/AN/A
22Pilot Program: Sharing “Health Hazard” Class 3 Sample Laboratory Results (HC3SLR) with Foreign Government Competent Authorities (FGCA)OIPOffice of International Programs - Latin America OfficeN/AN/A
23Food Safety Conference in the Middle East (Cairo)OIPOffice of International Programs - Middle East and North Africa OfficeN/AN/A
24Middle East and North Africa Region Science-based Food Safety System CourseOIPOffice of International Programs - Middle East and North Africa OfficeN/AN/A
25Non-Public Information Sharing ProgramOIPOffice of International Programs - Office of Global EngagementN/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.